|
Model Number 560BCS1 |
Device Problem
Electrical /Electronic Property Problem (1198)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/03/2020 |
Event Type
malfunction
|
Event Description
|
Medtronic received information that prior to use this bio-console instrument had a communication error and a comprehensive inspection has been requested.The customer stated that initially, the error was restored by turning the power on and off several times, and the timing overlapped with the one of maintenance and inspection, so no reports were given regarding the defect.However, after maintenance, the voltage system error log was confirmed and the customer requested to submit a defect report.The instrument was replaced with a back-up and there was no adverse patient effect.Additional information: the hand crank was not used to maintain flow at any stage.Additional information received - the details could not be confirmed because the situation was urgent at the site, but according to the me, it was heard that such resuscitation measures were a little prolonged.When this event occurred, immediately replaced the instrument with another one in the hospital and the issue was resolved.
|
|
Manufacturer Narrative
|
Device evaluation summary: the reported communication error was verified during service.The service technician was unable to reproduce the reported issue, but an error in the voltage control system was observed and the operation of the main board was unstable.The issue was resolved by replacing the sc board.Post-repair testing and preventative maintenance were performed per specifications.Conclusion: complaint confirmed for the reported communication error was verified during service.There were no patient/clinical safety issues reported.The service history record was not reviewed as returned product analysis found no evidence of servicing issues with the serviced device.Trends for issues with this product are reviewed at quarterly quality meetings.This regulatory report is being submitted as part of a retrospective review and remediation per (b)(4) as part of a capa action.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|